{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:17:48Z","timestamp":1776352668035,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s12325-015-0199-z","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T02:12:17Z","timestamp":1428027137000},"page":"341-355","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study"],"prefix":"10.1007","volume":"32","author":[{"given":"Erin K.","family":"Buysman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Hammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"199_CR1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. In: Department of Health and Human Services, editor. Atlanta, GA. 2014. http:\/\/www.cdc.gov\/diabetes\/pubs\/statsreport14\/national-diabetes-report-web.pdf . Accessed 15 Nov 2015."},{"key":"199_CR2","doi-asserted-by":"crossref","unstructured":"American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes care. 2013;36(4):1033\u201346.","DOI":"10.2337\/dc12-2625"},{"issue":"1","key":"199_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pop.2007.01.001","volume":"34","author":"WF Miser","year":"2007","unstructured":"Miser WF. The management of type 2 diabetes mellitus focus on quality. Prim Care. 2007;34(1):1\u201338.","journal-title":"Prim Care"},{"key":"199_CR4","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"199_CR5","doi-asserted-by":"crossref","unstructured":"American Diabetes A. Standards of medical care in diabetes\u20142012. Diabetes care. 2012;35 (Suppl 1):S11\u2013S63.","DOI":"10.2337\/dc12-s011"},{"issue":"5","key":"199_CR6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjmed.2008.09.047","volume":"122","author":"BM Cheung","year":"2009","unstructured":"Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KS. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122(5):443\u201353.","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"199_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S2.1","volume":"17","author":"Y Handelsman","year":"2011","unstructured":"Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2011;17(Suppl 2):1\u201353.","journal-title":"Endocr Pract: Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"issue":"6","key":"199_CR8","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","volume":"35","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364\u201379.","journal-title":"Diabetes Care"},{"issue":"1","key":"199_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","volume":"11","author":"JA Cramer","year":"2008","unstructured":"Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2008;11(1):44\u20137.","journal-title":"Value Health: J Int Soc Pharmacoecon Outcomes Res"},{"issue":"7","key":"199_CR10","first-page":"31","volume":"19","author":"WC Lee","year":"2006","unstructured":"Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface. 2006;19(7):31\u201341.","journal-title":"Manag Care Interface"},{"issue":"6","key":"199_CR11","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2337\/dc11-1277","volume":"35","author":"CJ Currie","year":"2012","unstructured":"Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012;35(6):1279\u201384.","journal-title":"Diabetes Care"},{"issue":"17","key":"199_CR12","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1001\/archinte.166.17.1836","volume":"166","author":"PM Ho","year":"2006","unstructured":"Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836\u201341.","journal-title":"Arch Intern Med"},{"issue":"12","key":"199_CR13","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.2337\/diacare.27.12.2800","volume":"27","author":"M Pladevall","year":"2004","unstructured":"Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800\u20135.","journal-title":"Diabetes Care"},{"issue":"2","key":"199_CR14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0145721705274927","volume":"31","author":"MK Rhee","year":"2005","unstructured":"Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, El-Kebbi IM, et al. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240\u201350.","journal-title":"Diabetes Educ"},{"issue":"3 Suppl","key":"199_CR15","first-page":"S43","volume":"18","author":"H Wild","year":"2012","unstructured":"Wild H. The economic rationale for adherence in the treatment of type 2 diabetes mellitus. Am J Manag Care. 2012;18(3 Suppl):S43\u20138.","journal-title":"Am J Manag Care"},{"issue":"2","key":"199_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diabres.2011.12.003","volume":"96","author":"A Nagrebetsky","year":"2012","unstructured":"Nagrebetsky A, Griffin S, Kinmonth AL, Sutton S, Craven A, Farmer A. Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age. Diabetes Res Clin Pract. 2012;96(2):119\u201328.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"199_CR17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2337\/dc08-1311","volume":"32","author":"BC Stuart","year":"2009","unstructured":"Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 2009;32(4):647\u20139.","journal-title":"Diabetes Care"},{"key":"199_CR18","unstructured":"Pharmacy Quality Alliance. PQA performance measures. 2014. http:\/\/pqaalliance.org\/measures\/default.asp . Accessed 10 Oct 2014."},{"key":"199_CR19","unstructured":"Centers for Medicare and Medicaid Services. Medicare Health and Drug Plan Quality and Performance Ratings 2013 Part C and Part D Technical Notes. 2013. http:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/Downloads\/Technical-Notes-2013-.pdf . Accessed 10 Oct 2014."},{"issue":"1","key":"199_CR20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1524-4733.2006.00139.x","volume":"10","author":"AM Peterson","year":"2007","unstructured":"Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health: J Int Soc Pharmacoecon Outcomes Res. 2007;10(1):3\u201312.","journal-title":"Value Health: J Int Soc Pharmacoecon Outcomes Res"},{"key":"199_CR21","unstructured":"HCUP CCS. Healthcare Cost and Utilization Project: Agency for Healthcare Research and Quality, Rockville, MD. 2014. http:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccs\/ccs.jsp . Accessed 15 Nov 2014."},{"issue":"1","key":"199_CR22","first-page":"15","volume":"14","author":"BA Young","year":"2008","unstructured":"Young BA, Lin E, Von Korff M, Simon G, Ciechanowski P, Ludman EJ, et al. Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care. 2008;14(1):15\u201323.","journal-title":"Am J Manag Care"},{"issue":"4","key":"199_CR23","first-page":"213","volume":"18","author":"HY Chang","year":"2012","unstructured":"Chang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Predicting costs with Diabetes Complications Severity Index in claims data. Am J Manag Care. 2012;18(4):213\u20139.","journal-title":"Am J Manag Care"},{"key":"199_CR24","unstructured":"US Department of Labor, Bureau of Labor Statistics. Consumer Price Index. Medical Care. Series ID: CUUR0000SAM Washington, DC: US Department of Labor, Bureau of Labor Statistics. 2012. http:\/\/data.bls.gov\/cgi-bin\/surveymost?su . Accessed 15 Nov 2014."},{"issue":"4","key":"199_CR25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0167-6296(01)00086-8","volume":"20","author":"WG Manning","year":"2001","unstructured":"Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461\u201394.","journal-title":"J Health Econ"},{"issue":"6","key":"199_CR26","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.clinthera.2013.03.021","volume":"35","author":"M Malmenas","year":"2013","unstructured":"Malmenas M, Bouchard JR, Langer J. Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8\u00a0mg or twice-daily exenatide 10 mug. Clin Ther. 2013;35(6):795\u2013807.","journal-title":"Clin Ther"},{"issue":"11","key":"199_CR27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s12325-014-0166-0","volume":"31","author":"SS Johnston","year":"2014","unstructured":"Johnston SS, Nguyen H, Felber E, Cappell K, Nelson JK, Chu BC, et al. Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States. Adv Ther. 2014;31(11):1119\u201333.","journal-title":"Adv Ther"},{"issue":"1","key":"199_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2011.02.002","volume":"93","author":"S Nam","year":"2011","unstructured":"Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"199_CR29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/0145721708320558","volume":"34","author":"PS Odegard","year":"2008","unstructured":"Odegard PS, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34(4):692\u20137.","journal-title":"Diabetes Educ"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0199-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T04:29:57Z","timestamp":1498192197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-015-0199-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["199"],"URL":"https:\/\/doi.org\/10.1007\/s12325-015-0199-z","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}